Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|December 1, 2000
Limited small-cell lung cancer: a potentially curable diseaseC A Sherman, C M Rocha Lima, A T TurrisiSeminars in Radiation Oncology|October 21, 2000
Radiation and chemotherapy for patients with stage III non-small cell lung cancerM R Green, C M Rocha Lima, C A ShermanOncology (Williston Park, N.Y.)|August 29, 2000
Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternativeF Cappuzzo, C M Rocha Lima, C A Sherman, et al.Anticancer Research|March 4, 2000
Synergistic effect of gemcitabine and irinotecan (CPT-11) on breast and small cell lung cancer cell linesH R Bahadori, C M Rocha Lima, M R Green, et al.Chest|January 30, 1999
The 1997 International Staging System for non-small cell lung cancer: have all the issues been addressed?S S Leong, C M Rocha Lima, C A Sherman, et al.Oncology (Williston Park, N.Y.)|February 28, 2001
Docetaxel followed by gemcitabine and irinotecan in solid tumorsC M Rocha Lima, J J Urbanic, C A Sherman, et al.Oncology (Williston Park, N.Y.)|April 17, 2001
Irinotecan/gemcitabine combination chemotherapy in pancreatic cancerC M Rocha Lima, C A Sherman, F J Brescia, et al.Seminars in Oncology|August 18, 2001
Beyond pancreatic cancer: irinotecan and gemcitabine in solid tumors and hematologic malignanciesC M Rocha Lima, J J Urbanic, A Lal, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902C M Rocha-Lima, J E Herndon, M E Lee, et al.American Journal of Clinical Oncology|February 7, 2007
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinomaRobert de W Marsh, C M Rocha Lima, D E Levy, et al.Pageof 2